PubMed Health⌕ Search

PubMed · 7231901

Human cataracta complicata. Clinicopathologic correlation.

Abstract

Complicated cataracts of the posterior subcapsular zone may be associated with a number os systemic conditions. Cataracts from patients with retinitis pigmentosa, Turner's syndrome, myotonic dystrophy, or those who were taking corticosteroids were examined clinically and pathologically after intracapsular cataract extraction. Two major types of posterior subcapsular opacities were observed: one type had multiple vacuoles, while the other type was a more solid appearing (plaque-like or snowball) opacity clinically. The predominant morphologic counterpart (by light and electron microscopy) of the vacuolar opacity is liquefactive necrosis with aberrantly migrated epithelia cells growing into the cataract. In the plaque-like or snowball opacity, the lens fibers are generally disorganized into round globules. The clinical significance is that the vacuolar-liquified posterior subcapsular cataract may be more easily removed by extracapsular methods than the plaque-like opacity; however, the proliferative cells in the vacuolar type are probably the source of an after-cataract membrane that may require discussion.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J Eshagian, N S Rafferty, W Goossens. 1981. Human cataracta complicata. Clinicopathologic correlation.. https://doi.org/10.1016/s0161-6420(81)35059-3

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Rituximab for treatment of opsoclonus-myoclonus syndrome in neuroblastoma.

Opsoclonus-myoclonus syndrome (OMS) is a rare paraneoplastic syndrome that occurs in 2%-3% of patients with neuroblastoma. The cause of this syndrome is believed to be immune mediated, but the exact mechanism still remains unclear. There is an urgent need to improve our current strategies for treating patients with OMS, as many patients have significant long-term neurologic deficits and behavior disorders with current treatment approaches. Therapies that have shown to improve symptoms in these patients have ranged from ACTH and corticosteroids, to intravenous gammaglobulin and plasmapheresis. We report our experience with Rituximab in a patient with neuroblastoma and OMS.

Adrenal Cortex Hormones↗

Cyclosporine sparing with mycophenolate mofetil, daclizumab and corticosteroids in renal allograft recipients: the CAESAR Study.

Although the calcineurin inhibitors (CNI) cyclosporine (CsA) and tacrolimus are highly effective immunosuppressants, they are associated with serious side effects. There is great interest in immunosuppressive regimens that permit reduction or elimination of CNIs, while maintaining adequate immunosuppression and acceptable acute rejection rates. Patients (n = 536) receiving their first renal allograft were randomized to one of three immunosuppressant regimens: daclizumab, mycophenolate mofetil (MMF), corticosteroids (CS) and low-dose CsA (target trough levels of 50-100 ng/mL), weaned from month 4 and withdrawn by month 6; daclizumab, MMF, CS and low-dose CsA; or MMF, CS and standard-dose CsA. Mean GFR 12 months after transplantation (primary end point) was not statistically different in the CsA withdrawal and low-dose CsA groups (both 50.9 mL/min/1.73 m(2)) vs. the standard-dose CsA group (48.6 mL/min/1.73 m(2)). At 12 months, the incidence of biopsy-proven acute rejection was significantly higher in the CsA withdrawal group (38%) vs. the low- or standard-dose CsA groups (25.4% and 27.5%, respectively; p < 0.05). In summary, a regimen of continuous low-dose CsA with MMF, CS and daclizumab induction is a clinically safe and effective immunosuppressive regimen in renal transplant recipients.

Adrenal Cortex Hormones↗